80043389 - Current Practices and Future Directions in Pulmonary, Critical Care and Sleep Medicine, The 15th Year

Current Practices and Future Directions in Pulmonary, Critical Care and Sleep Medicine, The 15th Year Banner

Date & Location
Thursday, August 10, 2017 7:00 AM - Sunday, August 13, 2017 12:00 PM   The Meritage, Napa, CA

Target Audience
Critical Care Medicine, Pulmonary Disease


More than 52 million Americans are living with chronic lung disease such as asthma, emphysema, chronic bronchitis and pulmonary fibrosis. Chronic Obstructive Pulmonary Disease (COPD) surpassed estimates and became the third leading cause of death in the United States, responsible for one in ten deaths. Chronic lung diseases caused an estimated 149,200 deaths in 2015, with lung cancer causing an additional 162,500 deaths in 2015. According to the CDC to Centers for Disease Control and Prevention (CDC) National Center for Health statistics, deaths from Chronic lower respiratory disease increased significantly from 2014 to 2015, with 41.6/100,000 deaths being attributed to chronic lower respiratory disease in 2015 (up from 40.5/100,000 in 2014). Not only are these conditions prevalent and morbid, the care results in considerable healthcare utilization and cost. The economic cost of COPD alone was $36 billion in 2014: $32.1 billion in direct health expenditures and $3.9 billion in absenteeism. In addition to being prevalent and morbid, chronic lung disease has become increasingly complex to manage given the overlay with comorbid disease and advancements in diagnostic modalities and therapeutic options. In 2015, 9 new drugs were approved by the U.S. Food and Drug Administration (FDA) for the management of chronic pulmonary diseases, and 3 additional new drugs were approved for lung diseases in 2016, ranging from COPD and asthma to Cystic Fibrosis (CF), lung cancer and pulmonary arterial hypertension. The recent burgeoning of anticoagulant therapies has resulted in new guidelines addressing the use of the many newly available medications for the various thromboembolism diagnoses.

Therefore, there is considerable need for greater education among caregivers to aid in the diagnosis and management of lung disease and critical illness. Further, given that the prevalence of diseases such as COPD are so high in the general population, it is of utmost importance to ensure that primary care doctors have access to up to date and impactful information about screening for and treatment of lung disease, such as that found in the extensive and newly updated Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, which changed the algorithm for grading the severity of COPD and prescribing therapy, including the addition of new treatments in this algorithm. Based on these needs and efforts, the Johns Hopkins Division of Pulmonary and Critical Care Medicine presents Current Practices and Future Directions in Pulmonary, Critical Care and Sleep Medicine: The 15th Year. This review course has been specifically designed to review the most recent innovations in pulmonary, critical care, and sleep medicine for the practicing physician, focusing on the importance of the primary care physician as the gateway to the diagnosis and treatment of lung disease.


  1. Describe new diagnostic and therapeutic advances in pulmonary disease.
  2. Identify new diagnostic and therapeutic advances in critical care medicine.
  3. Evaluate and manage patients with significant lung disease.
  4. Describe new diagnostic modalities and treatments in sleep medicine.

Please register on this website or call the Johns Hopkins University Office of Continuing Medical Education at (410) 502-9634.



The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The Johns Hopkins University School of Medicine designates this live activity for a maximum of 22 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 22 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 22 AAPA Category 1 CME credits for completing this program.

Application has been made to the American Association for Respiratory Care (AARC) for continuing education contact hours for respiratory therapists.

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. 

The Johns Hopkins University has approved this activity for 22 contact hours for non-physicians.